/
/
/

Accretion Pharmaceuticals Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
%

Share Price Live Stats

Open (₹)200.00
Volume (₹)2,400.00
High (₹)200.00
Upper Circuit210.00
Low (₹)196.00
Lower Circuit190.00
Prev Close202.00
52W High (₹)214.70
Price196.00
52W Low (₹)53.80

Share Market Cap & Key Ratios Overview

M.Cap (₹)224.54 Cr
Div. Yield (%)0.00
PE Ratio23.23
Debt to Equity0.24
Price to Book1.35
Book Value46.91
EPS (TTM)8.70
Face Value10.00
ROE (%)28.72

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
CIPLANSE
LAURUSLABSNSE
LUPINNSE
MANKINDNSE
DRREDDYNSE
AUROPHARMANSE
ACCPL-STNSE
LTP
1W Low
1W High
Market cap (₹)
1963+34 (1.76%)
1881.80
2183.80
4,56,833Cr
9555+390 (4.26%)
8750
10010
2,45,426Cr
4857-108.5 (-2.19%)
4711.50
5252.50
1,87,320Cr
1119.9-47.9 (-4.10%)
1086.40
1230
1,13,217Cr
1499+76 (5.34%)
1300
1523.50
1,12,212Cr
1784.8-76.8 (-4.13%)
1697.20
2024
1,01,155Cr
2321+168 (7.80%)
2004.50
2321
97,626Cr
2560.6+204.1 (8.66%)
2317
2560.60
96,859Cr
1279.8+108.8 (9.29%)
1151
1279.80
96,406Cr
1653.1-30.2 (-1.79%)
1603.50
1818.40
93,614Cr
196-11 (-5.31%)
196
210
225Cr

Key Highlights of Accretion Pharmaceuticals Ltd’s P&L

In 2026-03-31, Accretion Pharmaceuticals Ltd reported total revenue of ₹89.63Cr, compared with ₹57.38Cr in 2025-03-31, reflecting Accretion Pharmaceuticals Ltd turnover.

Depreciation was ₹1.21Cr and finance costs were ₹87.03Lakh in 2026-03-31

Profit Before Tax (PBT) has been ₹13.08Cr in 2026-03-31 as compared to ₹9.76Cr in 2025-03-31.

Net Profit (PAT) was ₹9.67Cr in 2026-03-31 compared with ₹6.79Cr in 2025-03-31.

Earnings per share (EPS) were ₹8.70 in 2026-03-31, compared with ₹8.32 in 2025-03-31.